Drugs

28 Mar

Clinical Trial Failures – Losses of 2016

Drug development costs are increasing and the time it takes to bring a drug to market is becoming longer. Also of consideration is the success rate for receiving regulatory approval to market your drug or device.The increasing cost of clinical research has significant implications for...

Read More

01 Mar

Key FDA Approved Drugs in 2016

While President Trump believes that  ‘slow and burdensome’  FDA drug approval process is ‘keeping too many new drugs from reaching the market’, former FDA Director Rob Califf differs in his opinion when he says that ‘Drug regulation drives innovation’.Rob Califf, a cardiologist goes on to...

Read More
traffic stats